Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Venturesomeness and PET measures of dopamine D2/D3 receptor availability

Amira Brown, Mark Mandelkern, Brittany Sumerel and Edythe London
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2010;
Amira Brown
1Psychiatry, University of California, Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Mandelkern
2Physics, University of California, Irvine, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Sumerel
1Psychiatry, University of California, Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edythe London
1Psychiatry, University of California, Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2010

Objectives Impulsivity is a multifactorial personality trait, described as the tendency to respond to stimuli recklessly without forethought, planning, or regard for the consequences. Previous findings suggest a link between dopamine (DA) neurotransmission and impulsivity, with disruptions in both being associated with psychiatric disorders and drug dependence. Recent studies have reported correlations between various measurements of impulsivity and DA D2 receptor availability, measured as binding potential (BPND) in mesolimbic and cortical brain regions. The goal of this study was to examine associations between subscale scores on the Impulsiveness-Venturesomeness-Empathy questionnaire in 15 non-smoking healthy males and DA D2 receptor availability, in subcortical brain regions using [18F]fallypride and PET.

Methods Image processing and volume-of-interest analyses were performed using a reference-region model, FSL FIRST and PMOD 3.1. Separate 2-group MANOVAs (Hotelling T-Square) were performed, comparing low (L) and high (H) scorers on the impulsiveness (7L, 8H), venturesomeness (6L, 9H) and empathy (6L, 9H) subscales. DA D2 receptor availability in the globus pallidus (GP), putamen (PU), caudate nucleus (CN), thalamus (TH), ventral tegmental area (VTA) and nucleus accumbens (NA) were the dependent variables; SPSS 20 was used.

Results There were no significant differences between the groups in age, education, injected dose or specific activities. We found a significant effect of group (L vs H groups) with venturesomeness but not with the other subscale scores. Scores on the venturesomeness subscale were correlated positively with DA D2 receptor availability in the GP and TH (p’s≤ 0.01), PU, VTA and NA (p’s ≤ 0.05). There were no other significant correlations.

Conclusions Our findings suggest that greater subcortical DA D2 receptor availability is associated with thrill-seeking and venturesomeness (a facet of impulsivity).

Research Support R03AA20190-01 NIAA

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

MANOVA

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Venturesomeness and PET measures of dopamine D2/D3 receptor availability
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Venturesomeness and PET measures of dopamine D2/D3 receptor availability
Amira Brown, Mark Mandelkern, Brittany Sumerel, Edythe London
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2010;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Venturesomeness and PET measures of dopamine D2/D3 receptor availability
Amira Brown, Mark Mandelkern, Brittany Sumerel, Edythe London
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2010;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

MTA II: Psychiatry Posters

  • Glutamatergic Abnormalities in a Rodent Model of Alcohol Abuse
  • Cognitive dysfunction in suicide attempters with charcoal burning may not be attributed to a single mechanism: a combined SPECT and MRS study
  • Brain imaging of dopamine D2/D3 receptors of 18F-fallypride-PET in normal volunteers: An AMIC Ray-Scan 64 PET/CT clinical system clinical trial
Show more MTA II: Psychiatry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire